YY1AP1

YY1AP1 is a nuclear transcriptional co-activator that couples the YY1 transcription factor to chromatin remodeling machinery to control cell proliferation and lineage differentiation (PMID:14744866, PMID:27939641). It binds YY1 directly through two YY1-binding regions and carries an intrinsic transactivation domain mapped to residues 260–345, enhancing transcription from YY1-responsive promoters (PMID:14744866). YY1AP1 is a component of the INO80 chromatin remodeling complex, and its loss in vascular smooth muscle cells drives cell cycle arrest with p21/CDKN1A upregulation and impairs TGF-β-driven smooth muscle differentiation; biallelic loss-of-function mutations in YY1AP1 cause Grange syndrome and a fibromuscular dysplasia-like vascular disease (PMID:27939641). In EpCAM+AFP+ hepatocellular carcinoma, YY1AP1 cooperates with YY1 to remodel the chromatin landscape and activate stemness gene programs, and its silencing eliminates oncogene addiction, triggering apoptosis and suppressing tumor growth (PMID:25597408). Beyond these contexts, the upstream signals regulating YY1AP1 activity remain largely uncharacterized in the available corpus.

1. 2004 High

   Established that YY1AP1 is a direct physical partner and co-activator of YY1, defining its core molecular function as transcriptional enhancement rather than an independent activity.

   Evidence Yeast two-hybrid, GST pull-down, co-IP, immunostaining, and luciferase reporter assays, with transactivation domain mapped to aa 260–345

   PMID:14744866

   Open questions at the time

   • Does not identify the chromatin or co-factor machinery recruited by YY1AP1
   • Endogenous target genes not defined
   • Mechanism of transactivation by the 260–345 domain unresolved
2. 2004 Medium

   Defined YY1AP1 as a ubiquitously expressed nuclear protein, fixing its compartment of action.

   Evidence Northern blot, immunostaining, 5'-RACE/cDNA cloning placing the gene at 1q21.3 encoding a 750-aa protein

   PMID:14744866

   Open questions at the time

   • Does not address tissue-specific functional roles despite ubiquitous expression
   • No sub-nuclear localization detail
3. 2015 High

   Showed that YY1AP1, with YY1, reprograms chromatin to sustain stemness programs in a hepatocellular carcinoma subtype, linking the co-activator to oncogenic cell-state maintenance.

   Evidence siRNA knockdown, in vitro apoptosis assays, in vivo xenograft suppression, and chromatin/transcriptomic landscape analysis in EpCAM+AFP+ HCC

   PMID:25597408

   Open questions at the time

   • Specific stemness target genes and direct chromatin binding sites not enumerated
   • Does not define the remodeling complex mediating the chromatin changes in this context
4. 2016 High

   Identified YY1AP1 as a subunit of the INO80 chromatin remodeling complex and as a disease gene, connecting its molecular partnership to proliferation control, smooth muscle differentiation, and human vascular pathology.

   Evidence Exome sequencing of patient families, reciprocal co-IP with INO80 components, cellular fractionation, siRNA knockdown in vascular smooth muscle cells with cell cycle, p21, and TGF-β differentiation assays

   PMID:27939641

   Open questions at the time

   • Structural position of YY1AP1 within INO80 not defined
   • Mechanistic link between INO80 membership and YY1 co-activation not directly resolved
   • How p21 upregulation is triggered mechanistically unclear
5. 2019 Low

   Raised the possibility that YY1AP1 nuclear activity is post-translationally regulated by AKT signaling, addressing how the co-activator's localization might be controlled.

   Evidence Western blot of phospho-YY1AP1, immunofluorescence of nuclear localization, and IGF1 pharmacological rescue within a SRC/AKT/STAT3/YY1AP1 axis in renal carcinoma cells

   PMID:31354472

   Open questions at the time

   • Phosphorylation sites and direct kinase not identified
   • Pathway placement of YY1AP1 is indirect
   • Functional consequence of altered phosphorylation on YY1 co-activation not tested

• How INO80 membership, YY1 co-activation, and post-translational regulation integrate to select target genes in a given cell type remains unresolved.
• No direct genome-wide binding map for YY1AP1
• Structural basis of complex assembly unknown
• Upstream signals controlling context-specific activity uncharacterized